PRIDOPIDINE, Pridopidine placebo
PL101-ALS301
Phase 3 small_molecule active
Quick answer
PRIDOPIDINE, Pridopidine placebo for Amyotrophic Lateral Sclerosis is a Phase 3 program (small_molecule) at Ferrer Internacional S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ferrer Internacional S.A.
- Indication
- Amyotrophic Lateral Sclerosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active